Clinical Trial Details
| Trial ID: | L7379 |
| Source ID: | NCT00909051 |
| Associated Drug: | Acarbose (Glucobay, Bayg5421) |
| Title: | GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus |
| Interventions: | DRUG: Acarbose (Glucobay, BAYG5421) |
| Outcome Measures: | Primary: Data collection on patients weight and waist circumference, fasting blood glucose, postprandial blood glucose (2h), HbA1C; exploratory analysis according to patient groups (concomitant cardiovascular disease groups, BMI), During observation period of three months | |
| Sponsor/Collaborators: | Sponsor: Bayer |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 15729 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2009-03-24 |
| Completion Date: | 2010-12-31 |
| Results First Posted: | |
| Last Update Posted: | 2023-06-06 |
| Locations: | Multiple Locations, Algeria|Multiple Locations, Bosnia and Herzegovina|Multiple Locations, Cambodia|Multiple Locations, China|Multiple Locations, Hong Kong|Multiple Locations, India|Multiple Locations, Indonesia|Multiple Locations, Korea, Republic of|Multiple Locations, Malaysia|Multiple Locations, Moldova, Republic of|Multiple Locations, Pakistan|Multiple Locations, Philippines|Multiple Locations, Russian Federation|Multiple Locations, Singapore|Multiple Locations, Thailand|Multiple Locations, Vietnam |
| URL: | https://clinicaltrials.gov/show/NCT00909051 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|